The process of modifying the preparation, for those who have made an appointment for the first dose with the AstraZeneca vaccine clarifies with its announcement the National Vaccination Committee.
As announced during the briefing of the Ministry of Health, on Monday, The recommendation for the AstraZeneca vaccine is modified and will now only be given to people over the age of 60 years.
At the present stage in our country the spread levels of the coronavirus are moderate to low and have a constant tendency for further reduction, The National Vaccination Committee recommends vaccination with the first dose of the AstraZeneca vaccine for individuals 60 years and older, in which the benefit of vaccination clearly outweighs the risk of thrombosis with thrombocytopenia.
Those interested in the vaccine change will be notified via SMS
Based on these, those who have a scheduled first dose of AstraZeneca under the age of 60 years, will receive an informative sms about the Commission decision and the recommendation, if they want to change vaccine.
It is noted that as many as 30-59 year olds wish to start their vaccination (1the dose) with the AstraZeneca vaccine because they consider that they have a high or moderate risk of Covid-19 disease due to their condition and lifestyle and / or prefer their faster vaccination, it will be possible to choose this vaccine.
The risk picture for thrombosis after AstraZeneca vaccine
In fact, The Communication provides a detailed table assessing the risk of vaccine side effects compared to the risk of severe coronavirus disease or death., by age.
Which categories of citizens can change the second dose of the vaccine
As announced yesterday, people who have already received the first dose of the AstraZeneca vaccine, regardless of age, It is recommended to continue the 2nd dose normally with the same vaccine.
They are exempt from this recommendation:
1.People of all ages who during the first weeks after the first dose showed severe side effects, with or without thrombocytopenia. The second dose should be given with another vaccine. In these cases, a relevant request is made by the treating physician to the competent committee (through emvolio.gov.gr).
2.People of all ages who have another special reason to get the 2nd dose of their vaccine with another vaccine. It will be possible to replace the 2nd dose vaccine after approval of a reasoned request by the treating physician to the competent committee (through emvolio.gov.gr).
3.People younger than 30 years who for any reason did the first dose of vaccination with the AstraZeneca vaccine. It is recommended that the second dose be given with another vaccine, unless, for reasons of faster immunization or other reasons, wish to continue with the 2nd dose of AstraZeneca vaccine.
In the above cases, one of the available mfNA vaccines from Pfizer or Moderna will be selected.
What do we know about the mixed vaccination regimen?
The Commission notes that the effectiveness of the mixed vaccination regimen has not yet been established (first dose with AstraZeneca vaccine, second dose with mRNA technology vaccine, i.e.. Moderna or Pfizer vaccine) in terms of the protection it provides against Covid-19 disease.
However, The effectiveness of the regimen for the prevention of the disease is reasonably probable as there are findings of studies that show a strong immune response from the mixed regimen, All vaccines - regardless of technology - are aimed at the "pin protein" of the virus and mixed regimens have been shown to be effective in the case of other vaccines..
It should also be mentioned that the vaccine with the mixed scheme (first dose with AstraZeneca vaccine, second dose with mRNA vaccine) more often causes mild or moderate reactions after the 2nd dose (e.g. pain at the injection site, fever, headache, fatigue etc.). Some European countries have already adopted the mixed regimen after the first dose with the AstraZeneca vaccine